Cargando…
MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1
The aim of this study was to explore the specific role of miR-29c-3p in Alzheimer's disease (AD). Animal models of AD were established by injecting streptozotocin (STZ) into mice through the lateral ventricle, while cell models of AD were induced by 10 μM β-amyloid (Aβ). We detected miR-29c-3p...
Autores principales: | Cao, Yanqun, Tan, Xiangxiang, Lu, Quzhe, Huang, Kai, Tang, Xiaoer, He, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695038/ https://www.ncbi.nlm.nih.gov/pubmed/34956559 http://dx.doi.org/10.1155/2021/2031407 |
Ejemplares similares
-
miR-590-3 and SP1 Promote Neuronal Apoptosis in Patients with Alzheimer's Disease via AMPK Signaling Pathway
por: Cao, Yanqun, et al.
Publicado: (2021) -
miR-15b represses BACE1 expression in sporadic Alzheimer’s disease
por: Gong, Guohua, et al.
Publicado: (2017) -
MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1
por: An, Fengmao, et al.
Publicado: (2017) -
Correction: MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1
por: An, Fengmao, et al.
Publicado: (2018) -
Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
por: Pereira, Patrícia A., et al.
Publicado: (2016)